| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | BMS-270394 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.4 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.058 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |